Conference Proceedings

Bortezomib and dexamethasone from cycle 1 as treatment and maintenance for multiple myeloma relapse (The BoMeR trial): Impact on response and time to progression

SJ Harrison, H Quach, J Dean, A Milner, MC Copeman, HM Prince

JOURNAL OF CLINICAL ONCOLOGY | AMER SOC CLINICAL ONCOLOGY | Published : 2010

DOI: 10.1200/jco.2010.28.15_suppl.8151

University of Melbourne Researchers

Citation metrics

3Web of Science
5Dimensions

Keywords

3201 Cardiovascular Medicine and Haematology
Life Sciences & Biomedicine
Oncology
Science & Technology
Rare Diseases
Cancer
6.1 Pharmaceuticals
Hematology
32 Biomedical and Clinical Sciences
Orphan Drug